Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Pancatalytic Medicine: A Paradigm for Non-Toxic Disease Treatment
1Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
Abstract:
The traditional disease treatment strategies typically encounter low therapeutic efficacy and high side effects originating from toxic drugs or surgeries, necessitating nontoxic approaches. The emerging pancatalytic medicine, rooted in respecting body ecology, offers a nontoxic protocol via catalyst preparation (P), biological effect activation (A), and versatile disease nontoxic-treatment (N). By precisely delivering catalysts to disease sites, it enables in situ catalytic chemical reactions that specifically target pathological microenvironments, e.g., generating radicals to oxidize cancer cell components or modulating inflammatory mediators, without disrupting the body's ecological balance. This strategy mirrors ecological principles by preserving normal tissue homeostasis, as catalysts only activate therapeutic catalytic reactions at the target locus, minimizing off-target toxicity. Pancatalytic therapy (PCT) thus embodies a paradigm shift, integrating body ecology to achieve both therapeutic specificity and systemic safety, heralding a revolutionary direction for nontoxic disease therapeutics.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...

